The Klinique Medical Clinic PCLBKK:KLINIQ +1.96%91 PE Ratio without NRI is 14.29 as of Jul. 05, 2026, which is 46% below its 10-year median of 26.67. GuruFocus rates BKK:KLINIQ with a GF Score™ of 91/100 and a GF Value™ of ฿44.60 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 69 Personal Services companies, The Klinique Medical Clinic PCL ranks better than 53.62% on this metric.
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-07-05), The Klinique Medical Clinic PCL's share price is ฿26.00.
The Klinique Medical Clinic PCL's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was ฿1.82. Therefore, The Klinique Medical Clinic PCL's PE Ratio without NRI for today is 14.29.
During the past 7 years, The Klinique Medical Clinic PCL's highest PE Ratio without NRI was 47.57. The lowest was 12.38. And the median was 26.67.
The Klinique Medical Clinic PCL (BKK:KLINIQ) PE Ratio without NRI Explanation
The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.
If a company loses money, the PE Ratio becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.
Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.
The Klinique Medical Clinic PCL PE Ratio without NRI Related Terms
The Klinique Medical Clinic PCL PE Ratio without NRI Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Klinique Medical Clinic PCL PE Ratio without NRI Chart
BKK:KLINIQ vs ROL, SCI, FTDR: PE Ratio without NRI Comparison
For the Personal Services subindustry, The Klinique Medical Clinic PCL's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Klinique Medical Clinic PCL PE Ratio without NRI vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, The Klinique Medical Clinic PCL's PE Ratio without NRI distribution charts can be found below:
* The bar in red indicates where The Klinique Medical Clinic PCL's PE Ratio without NRI falls into.
The Klinique Medical Clinic PCL PE Ratio without NRI Calculation
The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.
The Klinique Medical Clinic PCL's Share Price of today is ฿26.00.
The Klinique Medical Clinic PCL's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿1.82.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.
For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
The Klinique Medical Clinic PCL (BKK:KLINIQ) has a PE Ratio without NRI of 14.29 as of Jul. 05, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on The Klinique Medical Clinic PCL and its competitors. This is 46% below median its historical median of 26.67. Over the past decade, The Klinique Medical Clinic PCL's PE Ratio without NRI has ranged from 12.38 to 47.57. According to the industry distribution chart, The Klinique Medical Clinic PCL ranks #32 out of 69 companies in the Personal Services industry, placing it in the top 46.4%.
Is The Klinique Medical Clinic PCL's PE Ratio without NRI too high?
The Klinique Medical Clinic PCL's current PE Ratio without NRI of 14.29 is 46% below median its 10-year median of 26.67. Over the past 10 years, this metric has ranged from a low of 12.38 to a high of 47.57. The Personal Services industry median PE Ratio without NRI is 14.39. The Klinique Medical Clinic PCL's value of 14.29 is 0.7% below this industry median. Based on the distribution chart, The Klinique Medical Clinic PCL ranks #32 out of 69 companies in the Personal Services industry, which is above the industry midpoint. Overall, The Klinique Medical Clinic PCL has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Klinique Medical Clinic PCL's PE Ratio without NRI compare to ROL and SCI?
According to the Personal Services industry distribution chart, The Klinique Medical Clinic PCL ranks #32 out of 69 companies for PE Ratio without NRI. This puts The Klinique Medical Clinic PCL in the upper half of its industry. The industry median PE Ratio without NRI is 14.39. The Klinique Medical Clinic PCL's value of 14.29 is 0.7% below this benchmark. Historically, The Klinique Medical Clinic PCL's own PE Ratio without NRI has ranged from 12.38 to 47.57 over the past decade. While the company's 10-year median is 26.67 vs. the industry median of 14.39, The Klinique Medical Clinic PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Personal Services company?
The median PE Ratio without NRI among Personal Services companies is 14.39, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Klinique Medical Clinic PCL's current PE Ratio without NRI of 14.29 is 0.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on The Klinique Medical Clinic PCL and its competitors. For the Personal Services industry, the median PE Ratio without NRI is 14.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Klinique Medical Clinic PCL's current PE Ratio without NRI is 14.29, which is 46% below median its own 10-year median of 26.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Klinique Medical Clinic PCL stock overvalued right now?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL (BKK:KLINIQ) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿44.60, compared to a current price of ฿26.00 — trading 41.7% below its estimated fair value. The current PE Ratio without NRI is 14.29, which is 46% below median its 10-year median of 26.67 and 0.7% below the Personal Services industry median of 14.39. The Klinique Medical Clinic PCL's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For The Klinique Medical Clinic PCL (BKK:KLINIQ), the current PE Ratio without NRI is 14.29 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Klinique Medical Clinic PCL (BKK:KLINIQ) Overvalued in 2026?
Based on GuruFocus' analysis, The Klinique Medical Clinic PCL stock appears to be undervalued.
The current stock price of ฿26.00 is trading 41.7% below its estimated GF Value™ of ฿44.60.
GuruFocus considers The Klinique Medical Clinic PCL to be Significantly Undervalued.
Key valuation signals for BKK:KLINIQ:
PE Ratio without NRI: 14.29 (46% below median its 10-year median of 26.67)
GF Value™: ฿44.60 vs. price of ฿26.00 (41.7% below fair value)
Industry Position: 0.7% below the Personal Services median (#32 of 69)
No single metric tells the full story. See the BKK:KLINIQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Klinique Medical Clinic PCL Business Description
The Klinique Medical Clinic PCL provides skin care services, beauty, skin care, body contouring, and surgery. including providing holistic care services. The company has a wide range of services and products to meet the needs of customers at all levels, such as facial treatment services, reducing redness, reducing dark spots, laser services for face lifting, face reshaping, skin care, Body shape by removing and dissolving fat, cosmetic surgery, etc. In addition, the company also sells cosmeceuticals. There are various types of products, such as Special Care, Clean & Prepare, Whitening Set, Sun Care, and Antioxidant. The group operates two core business segments: Skin medical services and distribution of cosmetics and medical cosmetics; and Surgery services.
91GF Score
Get the complete analysis for BKK:KLINIQ
PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:KLINIQ has been successfully added to your 
